News & insights
Explore our latest news, VaccinesWork features and explainers, and in-depth insight reports related to our work.
Latest news releases
View all releasesAn agreement announced today will cut the price of the RTS,S/AS01 malaria vaccine by approximately 40 per cent. The deal, executed by UNICEF and financially backed by Gavi, the Vaccine Alliance, is expected to generate around US$ 50 million in…
President Bio visits Gavi to advance immunisation and Gavi Leap reform
President Bio of Sierra Leone and Gavi CEO Dr Sania Nishtar discuss immunisation progress, sustainable health financing and global health reform.
Vaccines deliver over US$ 30 billion in economic benefits for lower-income countries in 2025
Gavi-supported immunisation generated more than US$ 30 billion in economic benefits in 2025, through lower healthcare costs and healthier, more productive populations.
Gavi for the media
Gavi for the media
Visit our dedicated media room to see our latest press releases and statements, updated key facts and figures, as well as contact details for our media team.
Latest publications
View all reports
Welcome to Gavi’s 2024 Annual Progress Report, the fourth of the 2021–2025 strategic period.
Welcome to Gavi’s 2023 Annual Progress Report, the third of the 2021–2025 strategic period.
